CANF
Can-Fite BioPharma Ltd.
There isn't enough reported data to score CANF yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
CANF Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
CANF's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CANF PE Valuation
CANF has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
CANF Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect CANF's revenue to decline, with its earnings and profitability holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
CANF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2023 | -$2.00 | +$2.00 |
| Q4 2022 | -$2.00 | +$4.00 |
| Q2 2022 | -$4.00 | -$2.00 |
| Q4 2021 | -$6.00 | +$2.00 |
| Q4 2020 | -$8.00 | +$14.00 |
| Q4 2019 | -$22.00 | -104% |
| Q4 2018 | $510.00 | -11% |
CANF is still losing money, but far less than before: $0.00 per share over the past year, against $22.00 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over CANF in the latest year-over-year earnings comparison.
CANF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $203K | -43% |
| Q2 2025 | $202K | -36% |
| Q4 2024 | $358K | +2% |
| Q2 2024 | $316K | -19% |
| Q4 2023 | $351K | -12% |
| Q2 2023 | $392K | -4.2% |
| Q4 2022 | $401K | -12% |
| Q2 2022 | $409K | +2.8% |
CANF's revenue has slid since its 2018 peak: $203,000 last quarter, down 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -2489% | -1435 points |
| Q2 2025 | -2425% | -1278 points |
| Q4 2024 | -1127% | +283 points |
| Q2 2024 | -1296% | -210 points |
| Q4 2023 | -1054% | +603 points |
| Q2 2023 | -1147% | +186 points |
| Q4 2022 | -1410% | +260 points |
| Q2 2022 | -1086% | +931 points |
CANF's operating margin was −2489% last quarter, down 1435 points from the same quarter a year ago, near the bottom of its range since 2017.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over CANF in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
CANF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$4.2M | -$596K |
| Q2 2025 | -$4.8M | -$713K |
| Q4 2024 | -$3.6M | -$207K |
| Q2 2024 | -$4M | +$1M |
| Q4 2023 | -$3.4M | +$1.3M |
| Q2 2023 | -$5M | +$1M |
| Q4 2022 | -$4.7M | +$1.7M |
| Q2 2022 | -$6.1M | -$2.6M |
CANF has burned cash in almost every quarter: −$17M over the past year, against −$19M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
CANF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +87% | +79.5M shares |
| 1 year | +4083% | +167M shares |
CANF has 171M diluted shares, up 4083% from a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over CANF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
CANF Net Leverage
CANF's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CANF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.8 | Oversold |
| Stochastic | 2.7 | Oversold |
CANF's weekly RSI is 27 (oversold) and its Stochastic is 3 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CANF PE vs Healthcare Sector
CANF has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CANF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.81 | 18% below |
| 20 week MA | $2.59 | 42% below |
| 50 week MA | $3.33 | 55% below |
| 100 week MA | $12.2 | 88% below |
| 200 week MA | $30.8 | 95% below |
CANF is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CANF on trend strength, trading above more of its moving averages.
CANF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $690.0 | $370.0 | -46% |
| 2021 | $370.0 | $274.0 | -26% |
| 2022 | $274.0 | $128.0 | -53% |
| 2023 | $128.0 | $44.0 | -66% |
| 2024 | $44.0 | $31.6 | -28% |
| 2025 | $31.6 | $4.28 | -86% |
| 2026 YTD | $4.28 | $1.49 | -65% |
CANF has finished every year since 2020 lower, and it's down 65% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over CANF on returns for 2026, with the stronger performance.